These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38733822)

  • 1. TGFBI: A novel therapeutic target for cancer.
    Huang H; Tang Q; Li S; Qin Y; Zhu G
    Int Immunopharmacol; 2024 Jun; 134():112180. PubMed ID: 38733822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis.
    Chiavarina B; Costanza B; Ronca R; Blomme A; Rezzola S; Chiodelli P; Giguelay A; Belthier G; Doumont G; Van Simaeys G; Lacroix S; Yokobori T; Erkhem-Ochir B; Balaguer P; Cavailles V; Fabbrizio E; Di Valentin E; Gofflot S; Detry O; Jerusalem G; Goldman S; Delvenne P; Bellahcène A; Pannequin J; Castronovo V; Turtoi A
    Theranostics; 2021; 11(4):1626-1640. PubMed ID: 33408771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFBI modulates tumour hypoxia and promotes breast cancer metastasis.
    Fico F; Santamaria-Martínez A
    Mol Oncol; 2020 Dec; 14(12):3198-3210. PubMed ID: 33080107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β-induced (TGFBI) protein in melanoma: a signature of high metastatic potential.
    Lauden L; Siewiera J; Boukouaci W; Ramgolam K; Mourah S; Lebbe C; Charron D; Aoudjit F; Jabrane-Ferrat N; Al-Daccak R
    J Invest Dermatol; 2014 Jun; 134(6):1675-1685. PubMed ID: 24499734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
    Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
    Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the extracellular matrix protein TGFBI in cancer.
    Corona A; Blobe GC
    Cell Signal; 2021 Aug; 84():110028. PubMed ID: 33940163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.
    Chen WY; Tsai YC; Yeh HL; Suau F; Jiang KC; Shao AN; Huang J; Liu YN
    Sci Signal; 2017 Aug; 10(492):. PubMed ID: 28811384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells.
    Nummela P; Lammi J; Soikkeli J; Saksela O; Laakkonen P; Hölttä E
    Am J Pathol; 2012 Apr; 180(4):1663-74. PubMed ID: 22326753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFBI expression is associated with a better response to chemotherapy in NSCLC.
    Irigoyen M; Pajares MJ; Agorreta J; Ponz-Sarvisé M; Salvo E; Lozano MD; Pío R; Gil-Bazo I; Rouzaut A
    Mol Cancer; 2010 May; 9():130. PubMed ID: 20509890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind αvβ3 integrin, leading to anti-angiogenic and anti-tumor effects.
    Son HN; Nam JO; Kim S; Kim IS
    Biochim Biophys Acta; 2013 Oct; 1833(10):2378-88. PubMed ID: 23792174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1.
    Al Shareef Z; Kardooni H; Murillo-Garzón V; Domenici G; Stylianakis E; Steel JH; Rabano M; Gorroño-Etxebarria I; Zabalza I; Vivanco MD; Waxman J; Kypta RM
    Oncogene; 2018 Sep; 37(39):5305-5324. PubMed ID: 29858602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of TGFBI (βig-H3) in gastrointestinal tract tumorigenesis.
    Han B; Cai H; Chen Y; Hu B; Luo H; Wu Y; Wu J
    Mol Cancer; 2015 Mar; 14():64. PubMed ID: 25889002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line.
    Sato T; Muramatsu T; Tanabe M; Inazawa J
    Cancer Sci; 2018 Nov; 109(11):3623-3633. PubMed ID: 30156359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.
    Ween MP; Oehler MK; Ricciardelli C
    Int J Mol Sci; 2012; 13(8):10461-10477. PubMed ID: 22949874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin M promotes mesenchymal stem cell-stimulated tumor growth through a paracrine mechanism involving periostin and TGFBI.
    Lee MJ; Heo SC; Shin SH; Kwon YW; Do EK; Suh DS; Yoon MS; Kim JH
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1869-77. PubMed ID: 23735324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epirubicin suppresses proliferative and metastatic potential by downregulating transforming growth factor-β-induced expression in urothelial carcinoma.
    Shang D; Song B; Liu Y
    Cancer Sci; 2018 Apr; 109(4):980-987. PubMed ID: 28940965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.
    Tumbarello DA; Temple J; Brenton JD
    Mol Cancer; 2012 May; 11():36. PubMed ID: 22640878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer.
    Lecker LSM; Berlato C; Maniati E; Delaine-Smith R; Pearce OMT; Heath O; Nichols SJ; Trevisan C; Novak M; McDermott J; Brenton JD; Cutillas PR; Rajeeve V; Hennino A; Drapkin R; Loessner D; Balkwill FR
    Cancer Res; 2021 Nov; 81(22):5706-5719. PubMed ID: 34561272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
    Guo SK; Shen MF; Yao HW; Liu YS
    Cell Physiol Biochem; 2018; 49(3):1097-1109. PubMed ID: 30196284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathway.
    Wen G; Hong M; Li B; Liao W; Cheng SK; Hu B; Calaf GM; Lu P; Partridge MA; Tong J; Hei TK
    Int J Oncol; 2011 Oct; 39(4):1001-9. PubMed ID: 21701776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.